Inhibitory Effect of Argatroban on Thrombin-Antithrombin III Complex after Percutaneous Transluminal Coronary Angloplasty

• References

• 1 Mabin TA, Holmes Jr DR, Smith HC, Vlietstra RE, Bove AA, Reeder GS, Chesebro JH, Bresnahan JF, Orszulak TA. Intercoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angloplasty. J Am Coll Cardiol 1985; 5: 198-202
• 2 Matuso T, Kario K, Sakamoto S, Yamada T, Miki T, Hirase T, Kobayasi H. Hereditary heparin cofactor II deficiency and coronary artery disease. Thrombo Res 1992; 65: 495-505
• 3 Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1991; 84: 232-243
• 4 Berry CN, Girardot C, Lecoffre C, Lunven C. Effects of the systhetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant hirudin. Thromb Haemost 1994; 72: 381-386
• 5 Fitzgerald DJ, Fitzgerald GA. Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc Natl Acad Sci USA 1987; 86: 7585-7589
• 6 Edit JF, Allison P, Noble S, Ashton J, Golino P, Ncatt J, Buja LM, Willerson JT. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 1989; 84: 18-27
• 7 Hijikata-okunomiya A, Okamoto S, Wanaka K. Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma anti- thrombin-III. Thrombo Res 1990; 59: 967-977
• 8 Chesebro JH, Lam JY T, Badimon L, Fuster V. Restenosis after percutaneous transluminal coronary angioplasty. A hemorrheologic response to injury Am J Cardiol 1987; 60: 10B-16B
• 9 Graham DJ, Alexander JJ. The effects of thrombin on bovine aortic endothelial and smooth muscle cells. J Vase Surg 1990; 11: 307-313